Rhythm Biosciences Ltd. (AU:RHY) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Rhythm Biosciences Ltd, a pioneer in cancer diagnostics, has announced significant changes to its board, including the retirement of long-serving directors Dr. Trevor Lockett and Mr. Lou Panaccio. Additionally, Susan MacLeman will transition from Deputy Chair to Non-Executive Director, while Gavin Fox-Smith joins as a new Independent, Non-Executive Director. These changes are aimed at optimizing the board’s structure as the company continues its mission to develop affordable, early cancer detection solutions.
For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.